Quince Therapeutics to Participate at Upcoming Investor Conferences

Rhea-AI Summary

Quince Therapeutics (Nasdaq: QNCX), a late-stage biotechnology company focusing on rare diseases, has announced its participation in three upcoming investor conferences:

1. 2024 Maxim Healthcare Virtual Summit: CEO and CMO Dirk Thye, M.D., will participate in a fireside chat on October 17, 2024, at 3:00 p.m. ET.

2. LD Micro Main Event XVII: COO and CBO Brendan Hannah will present a company overview on October 29, 2024, at 6:30 p.m. ET.

3. ThinkEquity Conference 2024: President Charles Ryan, J.D., Ph.D., will present a company overview on October 30, 2024, at 3:00 p.m. ET.

Webcasts and registration details for these events are available on Quince's Investor Relations website.

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)-- Quince Therapeutics, Inc. (Nasdaq: QNCX), a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases, today announced that management will present at three upcoming investor conferences:

• 2024 Maxim Healthcare Virtual Summit – Quince’s Chief Executive Officer and Chief Medical Officer Dirk Thye, M.D., will participate in a fireside chat on Thursday, October 17, 2024 beginning at 3:00 p.m. Eastern Time. Qualified investors can register here to access the live event.
• LD Micro Main Event XVII – Quince’s Chief Operating Officer and Chief Business Officer Brendan Hannah will present a company overview on Tuesday, October 29, 2024 beginning at 6:30 p.m. Eastern Time. Please register here to access the live presentation.
• The ThinkEquity Conference 2024 – Quince’s President Charles Ryan, J.D., Ph.D., will present a company overview on October 30, 2024 beginning at 3:00 p.m. Eastern Time. A webcast of the presentation will be accessible here on the Events page of Quince’s Investor Relations website.

About Quince Therapeutics

Quince Therapeutics (Nasdaq: QNCX) is a late-stage biotechnology company dedicated to unlocking the power of a patient’s own biology for the treatment of rare diseases. For more information on the company and its latest news, visit www.quincetx.com and follow Quince Therapeutics on social media platforms LinkedIn, Facebook, X, and YouTube.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241014846322/en/

Media & Investor Contact:

Stacy Roughan

Quince Therapeutics, Inc.

Vice President, Corporate Communications & Investor Relations

ir@quincetx.com

Source: Quince Therapeutics, Inc.

FAQ

What investor conferences will Quince Therapeutics (QNCX) attend in October 2024?

Quince Therapeutics will participate in three investor conferences in October 2024: the Maxim Healthcare Virtual Summit on October 17, LD Micro Main Event XVII on October 29, and the ThinkEquity Conference on October 30.

Who will represent Quince Therapeutics (QNCX) at the 2024 Maxim Healthcare Virtual Summit?

Dirk Thye, M.D., Chief Executive Officer and Chief Medical Officer of Quince Therapeutics, will participate in a fireside chat at the 2024 Maxim Healthcare Virtual Summit on October 17, 2024.

When is Quince Therapeutics (QNCX) presenting at the LD Micro Main Event XVII?

Quince Therapeutics' Chief Operating Officer and Chief Business Officer, Brendan Hannah, will present a company overview at the LD Micro Main Event XVII on October 29, 2024, at 6:30 p.m. Eastern Time.

What time is Quince Therapeutics (QNCX) presenting at the ThinkEquity Conference 2024?

Quince Therapeutics' President Charles Ryan, J.D., Ph.D., will present a company overview at the ThinkEquity Conference 2024 on October 30, 2024, at 3:00 p.m. Eastern Time.